US Bancorp’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66K | Sell |
277
-23,486
| -99% | -$225K | ﹤0.01% | 3802 |
|
|
2025
Q1 | $149K | Buy |
23,763
+16,937
| +248% | +$106K | ﹤0.01% | 2177 |
|
|
2024
Q4 | $55.4K | Buy |
6,826
+1,578
| +30% | +$12.8K | ﹤0.01% | 2684 |
|
|
2024
Q3 | $94.9K | Buy |
5,248
+1,166
| +29% | +$21.1K | ﹤0.01% | 2413 |
|
|
2024
Q2 | $42K | Buy |
4,082
+632
| +18% | +$6.51K | ﹤0.01% | 2757 |
|
|
2024
Q1 | $36.6K | Buy |
+3,450
| New | +$36.6K | ﹤0.01% | 2843 |
|
|
2023
Q4 | – | Sell |
-113
| Closed | -$1.17K | – | 4072 |
|
|
2023
Q3 | $1.17K | Hold |
113
| – | – | ﹤0.01% | 3721 |
|
|
2023
Q2 | $1.62K | Buy |
+113
| New | +$1.62K | ﹤0.01% | 3698 |
|
|
2023
Q1 | – | Sell |
-349
| Closed | -$3.92K | – | 4150 |
|
|
2022
Q4 | $3.92K | Sell |
349
-60
| -15% | -$673 | ﹤0.01% | 3583 |
|
|
2022
Q3 | $5K | Buy |
409
+291
| +247% | +$3.56K | ﹤0.01% | 3585 |
|
|
2022
Q2 | $1K | Sell |
118
-113
| -49% | -$958 | ﹤0.01% | 3961 |
|
|
2022
Q1 | $3K | Sell |
231
-462
| -67% | -$6K | ﹤0.01% | 3732 |
|
|
2021
Q4 | $14K | Buy |
693
+639
| +1,183% | +$12.9K | ﹤0.01% | 3279 |
|
|
2021
Q3 | $2K | Buy |
54
+37
| +218% | +$1.37K | ﹤0.01% | 3866 |
|
|
2021
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 3901 |
|